Human Babesiosis

Infectious Disease Clinics of North America

Volumn 22, Issue 3, 2008, Pages 469-488

  Vannier, Edouard ^a   Gewurz, Benjamin E ^b   Krause, Peter J ^c,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d Division of Pediatric Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DIETHYLTOLUAMIDE; FIPRONIL; PENTAMIDINE; PERMETHRIN; QUININE;

BABESIA; BABESIA BIGEMINA; BABESIOSIS; BOOPHILUS; BOOPHILUS ANNULATUS; CATTLE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DOMESTIC ANIMAL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; GASTROENTERITIS; HISTORY OF MEDICINE; HOSPITAL PATIENT; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; LABORATORY DIAGNOSIS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PARASITE VECTOR; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; TICK BORNE DISEASE; TINNITUS; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIPROTOZOAL AGENTS; ARACHNID VECTORS; BABESIA; BABESIOSIS; DIAGNOSIS, DIFFERENTIAL; DNA, PROTOZOAN; HUMANS; IXODIDAE; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; UNITED STATES; ZOONOSES;

EID: 50049097462     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.03.010     Document Type: Review

References (123)

1. Babes V. Sur l'hemoglobinurie bacterienne du boeuf. Comptes Rendus de l'Academie des Sciences 107 (1888) 692-694
2. Smith T, Kilborne FL. Investigations into the nature, causation, and prevention of Texas or southern cattle fever. US Department of Agriculture Bureau of Animal Industry 1891-92; Annual Report 8th-9th:177-304.
3. Levine N.D. Progress in taxonomy of the Apicomplexan protozoa. J Protozool 35 4 (1988) 518-520
4. Skrabalo Z., and Deanovic Z. Piroplasmosis in man; report of a case. Doc Med Geogr Trop 9 1 (1957) 11-16
5. Fitzpatrick J.E., Kennedy C.C., McGeown M.G., et al. Human case of piroplasmosis (babesiosis). Nature 217 5131 (1968) 861-862
6. Western K.A., Benson G.D., Gleason N.N., et al. Babesiosis in a Massachusetts resident. N Engl J Med 283 16 (1970) 854-856
7. Spielman A. Lyme disease and human babesiosis: evidence incriminating vector and reservoir hosts. In: Englund P.T., and Sher A. (Eds). The biology of parasitism (1988), Alan R. Liss, New York 147-165
8. Spielman A., Clifford C.M., Piesman J., et al. Human babesiosis on Nantucket Island, USA: description of the vector, Ixodes (Ixodes) dammini, n. sp. (Acarina: Ixodidae). J Med Entomol 15 3 (1979) 218-234
9. Spielman A., Etkind P., Piesman J., et al. Reservoir hosts of human babesiosis on Nantucket Island. Am J Trop Med Hyg 30 3 (1981) 560-565
10. Spielman A., Wilson M.L., Levine J.F., et al. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol 30 (1985) 439-460
11. Perkins M.E. Rhoptry organelles of apicomplexan parasites. Parasitol Today 8 1 (1992) 28-32
12. Mackenstedt U., Gauer M., Mehlhorn H., et al. Sexual cycle of Babesia divergens confirmed by DNA measurements. Parasitol Res 76 3 (1990) 199-206
13. Rudzinska M.A., Spielman A., Riek R.F., et al. Intraerythrocytic 'gametocytes' of Babesia microti and their maturation in ticks. Can J Zool 57 2 (1979) 424-434
14. Rudzinska M.A., Spielman A., Lewengrub S., et al. The sequence of developmental events of Babesia microti in the gut of Ixodes dammini. Protistologica 20 2 (1984) 649-663
15. Piesman J., and Spielman A. Babesia microti: infectivity of parasites from ticks for hamsters and white-footed mice. Exp Parasitol 53 2 (1982) 242-248
16. Krause P.J., Telford III S.R., Spielman A., et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 275 21 (1996) 1657-1660
17. Piesman J., and Spielman A. Human babesiosis on Nantucket Island: prevalence of Babesia microti in ticks. Am J Trop Med Hyg 29 5 (1980) 742-746
18. Healy G. The impact of cultural and environmental changes on the epidemiology and control of human babesiosis. Trans R Soc Trop Med Hyg 83 Suppl (1989) 35-38
19. Esernio-Jenssen D., Scimeca P.G., Benach J.L., et al. Transplacental/perinatal babesiosis. J Pediatr 110 4 (1987) 570-572
20. Fox L.M., Wingerter S., Ahmed A., et al. Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J 25 2 (2006) 169-173
21. Leiby D.A. Babesiosis and blood transfusion: flying under the radar. Vox Sang 90 3 (2006) 157-165
22. Eskow E.S., Krause P.J., Spielman A., et al. Southern extension of the range of human babesiosis in the eastern United States. J Clin Microbiol 37 6 (1999) 2051-2052
23. Herwaldt B.L., Neitzel D.F., Gorlin J.B., et al. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion 42 9 (2002) 1154-1158
24. Krause P.J., Telford III S.R., Ryan R., et al. Geographical and temporal distribution of babesial infection in Connecticut. J Clin Microbiol 29 1 (1991) 1-4
25. Meldrum S.C., Birkhead G.S., White D.J., et al. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis 15 6 (1992) 1019-1023
26. Steketee R.W., Eckman M.R., Burgess E.C., et al. Babesiosis in Wisconsin. A new focus of disease transmission. JAMA 253 18 (1985) 2675-2678
27. Beattie J.F., Michelson M.L., and Holman P.J. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 347 9 (2002) 697-698
28. Conrad P.A., Kjemtrup A.M., Carreno R.A., et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 36 7 (2006) 779-789
29. Herwaldt B., Persing D.H., Precigout E.A., et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 124 7 (1996) 643-650
30. Herwaldt B.L., de Bruyn G., Pieniazek N.J., et al. Babesia divergens-like infection, Washington State. Emerg Infect Dis 10 4 (2004) 622-629
31. Persing D.H., Herwaldt B.L., Glaser C., et al. Infection with a babesia-like organism in northern California. N Engl J Med 332 5 (1995) 298-303
32. Foppa I.M., Krause P.J., Spielman A., et al. Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis 8 7 (2002) 722-726
33. Gorenflot A., Moubri K., Precigout E., et al. Human babesiosis. Ann Trop Med Parasitol 92 4 (1998) 489-501
34. Herwaldt B.L., Caccio S., Gherlinzoni F., et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 9 8 (2003) 942-948
35. Hildebrandt A., Hunfeld K.P., Baier M., et al. First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis 26 8 (2007) 595-601
36. Hunfeld K.P., Hildebrandt A., and Gray J.S. Babesiosis: Recent insights into an ancient disease. Int J Parasitol (2008)
37. Meer-Scherrer L., Adelson M., Mordechai E., et al. Babesia microti infection in Europe. Curr Microbiol 48 6 (2004) 435-437
38. Kim J.Y., Cho S.H., Joo H.N., et al. First case of human babesiosis in Korea: detection and characterization of a novel type of Babesia sp. (KO1) similar to ovine babesia. J Clin Microbiol 45 6 (2007) 2084-2087
39. Marathe A., Tripathi J., Handa V., et al. Human babesiosis-a case report. Indian J Med Microbiol 23 4 (2005) 267-269
40. Shih C.M., Liu L.P., Chung W.C., et al. Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman. J Clin Microbiol 35 2 (1997) 450-454
41. Wei Q., Tsuji M., Zamoto A., et al. Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic. J Clin Microbiol 39 6 (2001) 2178-2183
42. Bush J.B., Isaacson M., Mohamed A.S., et al. Human babesiosis-a preliminary report of 2 suspected cases in South Africa. S Afr Med J 78 11 (1990) 699
43. Rios L., Alvarez G., and Blair S. Serological and parasitological study and report of the first case of human babesiosis in Colombia. Rev Soc Bras Med Trop 36 4 (2003) 493-498
44. Krause P.J., McKay K., Gadbaw J., et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 68 4 (2003) 431-436
45. Swanson S.J., Neitzel D., Reed K.D., et al. Coinfections acquired from Ixodes ticks. Clin Microbiol Rev 19 4 (2006) 708-727
46. Krause P.J., McKay K., Thompson C.A., et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 34 9 (2002) 1184-1191
47. Wilson M.E. A world guide to infections: diseases, distribution, diagnosis (1991), Oxford University Press, New York
48. Hatcher J.C., Greenberg P.D., Antique J., et al. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 32 8 (2001) 1117-1125
49. Ruebush II T.K., Juranek D.D., Chisholm E.S., et al. Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med 297 15 (1977) 825-827
50. White D.J., Talarico J., Chang H.G., et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 158 19 (1998) 2149-2154
51. Ruebush II T.K., Cassaday P.B., Marsh H.J., et al. Human babesiosis on Nantucket Island: clinical features. Ann Intern Med 86 (1977) 6-9
52. Sun T., Tenenbaum M.J., Greenspan J., et al. Morphologic and clinical observations in human infection with Babesia microti. J Infect Dis 148 2 (1983) 239-248
53. Wittner M., Rowin K.S., Tanowitz H.B., et al. Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96 5 (1982) 601-604
54. Mathewson H.O., Anderson A.E., and Hazard G.W. Self-limited babesiosis in a splenectomized child. Pediatr Infect Dis 3 2 (1984) 148-149
55. Ortiz J.M., and Eagle Jr. R.C. Ocular findings in human babesiosis (Nantucket fever). Am J Ophthalmol 93 3 (1982) 307-311
56. Krause P.J., Gewurz B.E., Hill D., et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 46 3 (2008) 370-376
57. Krause P.J., Spielman A., Telford III S.R., et al. Persistent parasitemia after acute babesiosis. N Engl J Med 339 3 (1998) 160-165
58. Benezra D., Brown A.E., Polsky B., et al. Babesiosis and infection with human immunodeficiency virus (HIV). Ann Intern Med 107 6 (1987) 944
59. Falagas M.E., and Klempner M.S. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 22 5 (1996) 809-812
60. Froberg M.K., Dannen D., and Bakken J.S. Babesiosis and HIV. Lancet 363 9410 (2004) 704
61. Haselbarth K., Tenter A.M., Brade V., et al. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol 297 3 (2007) 197-204
62. Rosner F., Zarrabi M.H., Benach J.L., et al. Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med 76 4 (1984) 696-701
63. Stowell C.P., Gelfand J.A., Shepard J.A., et al. Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea. N Engl J Med 356 22 (2007) 2313-2319
64. Vannier E., Borggraefe I., Telford III S.R., et al. Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 189 9 (2004) 1721-1728
65. Zintl A., Mulcahy G., Skerrett H.E., et al. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 16 4 (2003) 622-636
66. Filstein M.R., Benach J.L., White D.J., et al. Serosurvey for human babesiosis in New York. J Infect Dis 141 4 (1980) 518-521
67. Hsu N.H., and Cross J.H. Serologic survey for human babesiosis on Taiwan. Taiwan Yi Xue Hui Za Zhi 76 12 (1977) 950-954
68. Yokoyama N., Okamura M., and Igarashi I. Erythrocyte invasion by Babesia parasites: current advances in the elucidation of the molecular interactions between the protozoan ligands and host receptors in the invasion stage. Vet Parasitol 138 1-2 (2006) 22-32
69. Lobo C.A. Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell. Infect Immun 73 1 (2005) 649-651
70. O'Connor R.M., Lane T.J., Stroup S.E., et al. Characterization of a variant erythrocyte surface antigen (VESA1) expressed by Babesia bovis during antigenic variation. Mol Biochem Parasitol 89 2 (1997) 259-270
71. Allred D.R. Babesiosis: persistence in the face of adversity. Trends Parasitol 19 2 (2003) 51-55
72. Allred D.R., and Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol Biochem Parasitol 134 1 (2004) 27-35
73. O'Connor R.M., and Allred D.R. Selection of Babesia bovis-infected erythrocytes for adhesion to endothelial cells co-selects for altered variant erythrocyte surface antigen isoforms. J Immunol 164 4 (2000) 2037-2045
74. Kyes S., Horrocks P., and Newbold C. Antigenic variation at the infected red cell surface in malaria. Annu Rev Microbiol 55 (2001) 673-707
75. Dao A.H., and Eberhard M.L. Pathology of acute fatal babesiosis in hamsters experimentally infected with the WA-1 strain of Babesia. Lab Invest 74 5 (1996) 853-859
76. Everitt J.I., Shadduck J.A., Steinkamp C., et al. Experimental Babesia bovis infection in Holstein calves. Vet Pathol 23 5 (1986) 556-562
77. Hemmer R.M., Wozniak E.J., Lowenstine L.J., et al. Endothelial cell changes are associated with pulmonary edema and respiratory distress in mice infected with the WA1 human Babesia parasite. J Parasitol 85 3 (1999) 479-489
78. Clark I.A., Budd A.C., Hsue G., et al. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar J 5 (2006) 69
79. Fitzpatrick J.E., Kennedy C.C., McGeown M.G., et al. Further details of third recorded case of redwater (Babesiosis) in man. Br Med J 4 5686 (1969) 770-772
80. Chen D., Copeman D.B., Burnell J., et al. Helper T cell and antibody responses to infection of CBA mice with Babesia microti. Parasite Immunol 22 2 (2000) 81-88
81. Goff W.L., Johnson W.C., Tuo W., et al. Age-related innate immune response in calves to Babesia bovis involves IL-12 induction and IL-10 modulation. Ann N Y Acad Sci 969 (2002) 164-168
82. Aguilar-Delfin I., Wettstein P.J., and Persing D.H. Resistance to acute babesiosis is associated with interleukin-12- and gamma interferon-mediated responses and requires macrophages and natural killer cells. Infect Immun 71 4 (2003) 2002-2008
83. Clawson M.L., Paciorkowski N., Rajan T.V., et al. Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect Immun 70 9 (2002) 5304-5306
84. + T cells in the control of primary infection with Babesia microti in mice. J Protozool Res 4 (1994) 164-171
85. Wood P.R., and Clark I.A. Apparent irrelevance of NK cells to resolution of infections with Babesia microti and Plasmodium vinckei petteri in mice. Parasite Immunol 4 5 (1982) 319-327
86. Rosenblatt-Bin H., Klein A., and Sredni B. Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide. Parasite Immunol 18 6 (1996) 297-306
87. Shoda L.K., Palmer G.H., Florin-Christensen J., et al. Babesia bovis-stimulated macrophages express interleukin-1β, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro. Infect Immun 68 9 (2000) 5139-5145
88. + T cell lines from genetically diverse cattle. Exp Parasitol 91 1 (1999) 40-51
89. Goff W.L., Johnson W.C., Parish S.M., et al. IL-4 and IL-10 inhibition of IFN-γ- and TNF-α-dependent nitric oxide production from bovine mononuclear phagocytes exposed to Babesia bovis merozoites. Vet Immunol Immunopathol 84 3-4 (2002) 237-251
90. Hemmer R.M., Ferrick D.A., and Conrad P.A. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol Res 86 2 (2000) 121-128
91. Clark I.A., Alleva L.M., Mills A.C., et al. Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 17 3 (2004) 509-539
92. Krause P.J., Daily J., Telford S.R., et al. Shared features in the pathobiology of babesiosis and malaria. Trends Parasitol 23 12 (2007) 605-610
93. + T cell clones. J Vet Med Sci 60 4 (1998) 401-404
94. Hemmer R.M., Ferrick D.A., and Conrad P.A. Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp55-/- mice infected with the human Babesia WA1 parasite. J Parasitol 86 4 (2000) 736-742
95. Shimada T., Shikano S., Hashiguchi R., et al. Effects of depletion of T cell subpopulations on the course of infection and anti-parasite delayed type hypersensitivity response in mice infected with Babesia microti and Babesia rodhaini. J Vet Med Sci 58 4 (1996) 343-347
96. Cavacini L.A., Parke L.A., and Weidanz W.P. Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Infect Immun 58 9 (1990) 2946-2950
97. + T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect Immun 67 8 (1999) 4143-4148
98. Matsubara J., Koura M., and Kamiyama T. Infection of immunodeficient mice with a mouse-adapted substrain of the Gray strain of Babesia microti. J Parasitol 79 5 (1993) 783-786
99. Brownstein J.S., Holford T.R., and Fish D. A climate-based model predicts the spatial distribution of the Lyme disease vector Ixodes scapularis in the United States. Environ Health Perspect 111 9 (2003) 1152-1157
100. Healy G.R., and Ruebush II T.K. Morphology of Babesia microti in human blood smears. Am J Clin Pathol 73 1 (1980) 107-109
101. Krause P.J., Telford III S., Spielman A., et al. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol 34 11 (1996) 2791-2794
102. Persing D.H., Mathiesen D., Marshall W.F., et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 30 8 (1992) 2097-2103
103. Krause P.J., Ryan R., Telford III S., et al. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J Clin Microbiol 34 8 (1996) 2014-2016
104. Krause P.J., Telford III S.R., Ryan R., et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 169 4 (1994) 923-926
105. Ruebush II T.K., Chisholm E.S., Sulzer A.J., et al. Development and persistence of antibody in persons infected with Babesia microti. Am J Trop Med Hyg 30 1 (1981) 291-292
106. Homer M.J., Aguilar-Delfin I., Telford III S.R., et al. Babesiosis. Clin Microbiol Rev 13 3 (2000) 451-469
107. Krause P.J., Lepore T., Sikand V.K., et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 343 20 (2000) 1454-1458
108. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 9 (2006) 1089-1134
109. Raju M., Salazar J.C., Leopold H., et al. Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr Infect Dis J 26 2 (2007) 181-183
110. Raoult D., Soulayrol L., Toga B., et al. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med 107 6 (1987) 944
111. Cahill K.M., Benach J.L., Reich L.M., et al. Red cell exchange: treatment of babesiosis in a splenectomized patient. Transfusion 21 2 (1981) 193-198
112. Jacoby G.A., Hunt J.V., Kosinski K.S., et al. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med 303 19 (1980) 1098-1100
113. Powell V.I., and Grima K. Exchange transfusion for malaria and Babesia infection. Transfus Med Rev 16 3 (2002) 239-250
114. Vyas J.M., Telford S.R., and Robbins G.K. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clin Infect Dis 45 12 (2007) 1588-1590
115. Hayes E.B., and Piesman J. How can we prevent Lyme disease?. N Engl J Med 348 24 (2003) 2424-2430
116. Mather T.N., Ribeiro J.M., and Spielman A. Lyme disease and babesiosis: acaricide focused on potentially infected ticks. Am J Trop Med Hyg 36 3 (1987) 609-614
117. Needham G.R. Evaluation of five popular methods for tick removal. Pediatrics 75 6 (1985) 997-1002
118. Smith R.D., and Kakoma I. A reappraisal of vector control strategies for babesiosis. Trans R Soc Trop Med Hyg 83 Suppl (1989) 43-52
119. Stafford III K.C. Tick management handbook: an integrated guide for homeowners, pest control operators, and public health officials for the prevention of tick-associated disease (2007), The Connecticut Agricultural Experimental Station, New Haven p. 1-77
120. Tsao J.I., Wootton J.T., Bunikis J., et al. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci U S A 101 52 (2004) 18159-18164
121. Vazquez M., Muehlenbein C., Cartter M., et al. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis 14 2 (2008) 210-216
122. Wilson M.L., Telford III S.R., Piesman J., et al. Reduced abundance of immature Ixodes dammini (Acari: Ixodidae) following elimination of deer. J Med Entomol 25 4 (1988) 224-228
123. McQuiston J.H., Childs J.E., Chamberland M.E., et al. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 40 3 (2000) 274-284